Cargando…
Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma
SIMPLE SUMMARY: Immunotherapy targeting the programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) has attracted worldwide attention and is setting off a revolution in cancer treatment, bringing new hope to cancer patients. PD-L2 is another ligand of PD-1 and a promising immunotherapy marker. T...
Autores principales: | Tao, Yun-Yun, Shi, Yue, Gong, Xue-Qin, Li, Li, Li, Zu-Mao, Yang, Lin, Zhang, Xiao-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856314/ https://www.ncbi.nlm.nih.gov/pubmed/36672315 http://dx.doi.org/10.3390/cancers15020365 |
Ejemplares similares
-
Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2023) -
Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021) -
DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
por: Zheng, Jing, et al.
Publicado: (2023) -
Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma
por: Li, Yue-Ming, et al.
Publicado: (2022) -
Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
por: Chen, Yi-Di, et al.
Publicado: (2022)